SHP2:在癌症及其微观环境的接口处的一个类目标
Nicole M Sodir1, Gaurav Pathria2, Joanne I Adamkewicz3
1Department of Translational Oncology, Genentech, South San Francisco, California.
Cancer discovery
|September 8, 2023
概括
蛋白酸酶SHP2 (PTPN11) 是癌症的关键标,影响瘤生长和瘤微环境. SHP2抑制剂具有双重益处,内在和外在抑制癌症,并且是有前途的组合药物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- SHP2 (PTPN11) 是一种调节各种癌症增殖途径的蛋白质酸酶.
- 此外,SHP2在调节瘤微环境方面也起着至关重要的作用.
- 这种双重功能使SHP2成为癌症治疗的多方面的目标.
研究的目的:
- 审查SHP2在癌症和瘤微环境中的作用.
- 讨论使用SHP2抑制剂作为组合药物的临床策略.
- 突出SHP2抑制对改善治疗反应的潜力.
主要方法:
- 对癌症中SHP2功能研究的文献综述.
- 分析SHP2在瘤内在和外在途径中的作用.
- 检查临床试验数据和涉及SHP2抑制剂的临床前研究.
主要成果:
- 抑制SHP2阻碍了瘤生长,并重塑了瘤的微环境.
- SHP2 抑制剂显示出作为组合药物的潜力,增强治疗结果.
- 单剂SHP2抑制剂的活性可能是有限的,这强调了需要组合策略.
结论:
- SHP2是癌症扩散和瘤微环境的关键调节者.
- SHP2 抑制剂提供了一个有前途的治疗策略,特别是在组合疗法中.
- 准SHP2可以提高对癌症治疗的反应的深度和持久性.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Hedgehog Signaling Pathway
7.4K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


